Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies.

Clinical kidney journal·2026
Same author

Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial.

Journal of the American Society of Nephrology : JASN·2025
Same author

Electronic Patient File-Embedded Model-Informed Precision Dosing Compared with Physician Dosing of Tacrolimus in Kidney Transplantation.

Clinical pharmacology and therapeutics·2025
Same author

Current Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis.

Clinical pharmacology and therapeutics·2025
Same author

Belgian Consensus Guidelines Within Eurotransplant on Imlifidase-enabled Deceased Donor Kidney Transplantation in Highly Sensitized Patients.

Transplantation·2025
Same author

Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same journal

Awareness and outreach.

Nature clinical practice. Nephrology·2020
Same journal

Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms?

Nature clinical practice. Nephrology·2009
Same journal

Looking into the crystal ball: kidney transplantation in 2025.

Nature clinical practice. Nephrology·2009
Same journal

Depth of inflammation in Crohn's disease.

Nature clinical practice. Nephrology·2009
Same journal

Comment on "Home fingerprick sampling for immunosuppressant drug monitoring in pediatric renal transplant recipients".

Nature clinical practice. Nephrology·2009
Same journal

Does albumin resuscitation have a role in the early prevention of sepsis-associated acute kidney injury?

Nature clinical practice. Nephrology·2009
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Skin problems in chronic kidney disease.

Dirk R J Kuypers1

  • 1Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium. dirk.kuypers@uz.kuleuven.ac.be

Nature Clinical Practice. Nephrology
|February 5, 2009
PubMed
Summary
This summary is machine-generated.

Skin disorders like uremic pruritus and calcific uremic arteriolopathy significantly impact chronic kidney disease (CKD) patients. Research explores inflammation, opioidergic systems, and vascular calcification, with treatments like nalfurafine and bisphosphonates showing promise.

Related Experiment Videos

Last Updated: Jun 25, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Area of Science:

  • Nephrology
  • Dermatology
  • Internal Medicine

Background:

  • Skin disorders are common and debilitating complications in patients with chronic kidney disease (CKD).
  • These conditions significantly impair quality of life, affecting both mental and physical well-being.
  • Uremic pruritus and calcific uremic arteriolopathy are key examples of CKD-associated dermatological issues.

Purpose of the Study:

  • To review the pathogenesis and current treatment strategies for major skin disorders in CKD patients.
  • To highlight the role of inflammation and the opioidergic system in uremic pruritus.
  • To discuss therapeutic approaches for calcific uremic arteriolopathy and preventive measures for nephrogenic systemic fibrosis.

Main Methods:

  • Literature review of studies on skin disorders in chronic kidney disease.
  • Analysis of the pathophysiology of uremic pruritus, including inflammatory markers and the opioidergic system.
  • Evaluation of treatment options for uremic pruritus, calcific uremic arteriolopathy, and nephrogenic systemic fibrosis.

Main Results:

  • Uremic pruritus is an inflammatory systemic disease linked to increased inflammation biomarkers and potential opioidergic system imbalance.
  • Calcific uremic arteriolopathy results from an imbalance in vascular calcification regulators due to uremic inflammation.
  • Nephrogenic systemic fibrosis is a severe complication of gadolinium contrast agents in advanced CKD, with prevention being key.

Conclusions:

  • Effective management of uremic pruritus involves treatments like nalfurafine, while bisphosphonates and sodium thiosulfate are promising for calcific uremic arteriolopathy.
  • Preventing nephrogenic systemic fibrosis requires careful selection of contrast agents and consideration of patient's CKD stage.
  • Further research is needed to establish optimal management and potential therapies for these challenging conditions.